Clinical trial
Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults
NCT00435968 · CV Technologies, Industry · Completed
Key facts
| NCT number | NCT00435968 |
|---|---|
| Title | Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults |
| Official title | Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults |
| Lead sponsor | CV Technologies, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | CVT E002 (Cold-fX) |
| Enrollment | 50 |
| Start date | Mar 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 16, 2007 |
| Last update posted | Jul 17, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: